BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11258892)

  • 1. Semisynthetic derivatives of concanamycin A and C, as inhibitors of V- and P-type ATPases: structure-activity investigations and developments of photoaffinity probes.
    Dröse S; Boddien C; Gassel M; Ingenhorst G; Zeeck A; Altendorf K
    Biochemistry; 2001 Mar; 40(9):2816-25. PubMed ID: 11258892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c.
    Huss M; Ingenhorst G; König S; Gassel M; Dröse S; Zeeck A; Altendorf K; Wieczorek H
    J Biol Chem; 2002 Oct; 277(43):40544-8. PubMed ID: 12186879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1.
    Xie XS; Padron D; Liao X; Wang J; Roth MG; De Brabander JK
    J Biol Chem; 2004 May; 279(19):19755-63. PubMed ID: 14998996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.
    Gagliardi S; Rees M; Farina C
    Curr Med Chem; 1999 Dec; 6(12):1197-212. PubMed ID: 10519916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of the Kdp-ATPase of Escherichia coli.
    Altendorf K; Gassel M; Puppe W; Möllenkamp T; Zeeck A; Boddien C; Fendler K; Bamberg E; Dröse S
    Acta Physiol Scand Suppl; 1998 Aug; 643():137-46. PubMed ID: 9789555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases.
    Dröse S; Bindseil KU; Bowman EJ; Siebers A; Zeeck A; Altendorf K
    Biochemistry; 1993 Apr; 32(15):3902-6. PubMed ID: 8385991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Paracoccus halodenitrificans ATPase a chimeric enzyme?
    Hochstein LI
    FEMS Microbiol Lett; 1996 Jun; 140(1):55-60. PubMed ID: 11536735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases.
    Dröse S; Altendorf K
    J Exp Biol; 1997 Jan; 200(Pt 1):1-8. PubMed ID: 9023991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Archazolid and apicularen: novel specific V-ATPase inhibitors.
    Huss M; Sasse F; Kunze B; Jansen R; Steinmetz H; Ingenhorst G; Zeeck A; Wieczorek H
    BMC Biochem; 2005 Aug; 6():13. PubMed ID: 16080788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells.
    Manabe T; Yoshimori T; Henomatsu N; Tashiro Y
    J Cell Physiol; 1993 Dec; 157(3):445-52. PubMed ID: 8253855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthetic investigations of the V-type ATPase inhibitors bafilomycin A1, B1 and concanamycin A.
    Schuhmann T; Grond S
    J Antibiot (Tokyo); 2004 Oct; 57(10):655-61. PubMed ID: 15638326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
    Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
    J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular role of the V-ATPase in Neurospora crassa: analysis of mutants resistant to concanamycin or lacking the catalytic subunit A.
    Bowman EJ; Bowman BJ
    J Exp Biol; 2000 Jan; 203(Pt 1):97-106. PubMed ID: 10600678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
    Osteresch C; Bender T; Grond S; von Zezschwitz P; Kunze B; Jansen R; Huss M; Wieczorek H
    J Biol Chem; 2012 Sep; 287(38):31866-76. PubMed ID: 22815478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP; Keeling DJ
    Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative roles of Na+/H+ exchange and vacuolar-type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages.
    Swallow CJ; Grinstein S; Sudsbury RA; Rotstein OD
    J Cell Physiol; 1993 Dec; 157(3):453-60. PubMed ID: 8253856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concanamycin and indolyl pentadieneamide inhibitors of the vacuolar H+-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain.
    Whyteside G; Meek PJ; Ball SK; Dixon N; Finbow ME; Kee TP; Findlay JB; Harrison MA
    Biochemistry; 2005 Nov; 44(45):15024-31. PubMed ID: 16274249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic properties of Na(+)-translocating V-ATPase in Enterococcus hirae.
    Murata T; Kawano M; Igarashi K; Yamato I; Kakinuma Y
    Biochim Biophys Acta; 2001 May; 1505(1):75-81. PubMed ID: 11248190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a series of vacuolar type H(+)-ATPase inhibitors on CTL-mediated cytotoxicity.
    Togashi K; Kataoka T; Nagai K
    Immunol Lett; 1997 Mar; 55(3):139-44. PubMed ID: 9161879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.